Background Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease
worldwide and the leading cause of liver-related morbidity and mortality. We aimed to predict …

Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide
with a complex etiology attributed to behavioural, environmental, and genetic causes. The …

Background & Aims Functional bowel disorders (FBDs) are the most common gastrointestinal
problems managed by physicians. We aimed to assess the burden of chronic symptomatic …

Treatment options for refractory hepatic encephalopathy (HE) are limited. Patients who fail
medical management may harbor large portosystemic shunts (PSSs) which are possible …

Background & Aims Coronavirus disease 2019 (COVID-19) pandemic lockdown and restrictions
had significant disruption to patient care. We aimed to evaluate the impact of COVID-19 …

Background The burden of cirrhosis on the healthcare system is substantial and growing.
Our objectives were to estimate the readmission rates and hospitalization costs as well as to …

Despite COVID-19’s significant morbidity and mortality, considering cost-effectiveness of
pharmacologic treatment strategies for hospitalized patients remains critical to support …

Healthy sexual function is important to maintain a good quality of life but is frequently impaired
in patients with cirrhosis. The degree of sexual dysfunction appears to be linked with the …

Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent worldwide. Identifying
high-risk patients is critical to best utilize limited health care resources. We established a …

METHODS: National-level healthcare expenditure data developed by the Institute for Health
Metrics and Evaluations for the Disease Expenditure Project and prevalence of CLDs and …